Literature DB >> 27113527

Removing or truncating connexin 43 in murine osteocytes alters cortical geometry, nanoscale morphology, and tissue mechanics in the tibia.

Max A Hammond1, Alycia G Berman2, Rafael Pacheco-Costa3, Hannah M Davis3, Lilian I Plotkin4, Joseph M Wallace5.   

Abstract

Gap junctions are formed from ubiquitously expressed proteins called connexins that allow the transfer of small signaling molecules between adjacent cells. Gap junctions are especially important for signaling between osteocytes and other bone cell types. The most abundant type of connexin in bone is connexin 43 (Cx43). The C-terminal domain of Cx43 is thought to be an important modulator of gap junction function but the role that this domain plays in regulating tissue-level mechanics is largely unknown. We hypothesized that the lack of the C-terminal domain of Cx43 would cause morphological and compositional changes as well as differences in how bone responds to reference point indentation (RPI) and fracture toughness testing. The effects of the C-terminal domain of Cx43 in osteocytes and other cell types were assessed in a murine model (C57BL/6 background). Mice with endogenous Cx43 in their osteocytes removed via a Cre-loxP system were crossed with knock-in mice which expressed Cx43 that lacked the C-terminal domain in all cell types due to the insertion of a truncated allele to produce the four groups used in the study. The main effect of removing the C-terminal domain from osteocytic Cx43 increased cortical mineral crystallinity (p=0.036) and decreased fracture toughness (p=0.017). The main effect of the presence of the C-terminal domain in other cell types increased trabecular thickness (p<0.001), cortical thickness (p=0.008), and average RPI unloading slope (p=0.004). Collagen morphology was altered when either osteocytes lacked Cx43 (p=0.008) or some truncated Cx43 was expressed in all cell types (p<0.001) compared to controls but not when only the truncated form of Cx43 was expressed in osteocytes (p=0.641). In conclusion, the presence of the C-terminal domain of Cx43 in osteocytes and other cell types is important to maintain normal structure and mechanical integrity of bone.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atomic force microscopy; Bone; Fracture toughness; Raman spectroscopy; Reference point indentation; Type I collagen

Mesh:

Substances:

Year:  2016        PMID: 27113527      PMCID: PMC4899203          DOI: 10.1016/j.bone.2016.04.021

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  23 in total

Review 1.  Gap junctions.

Authors:  Daniel A Goodenough; David L Paul
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-07       Impact factor: 10.005

Review 2.  Beyond the gap: functions of unpaired connexon channels.

Authors:  Daniel A Goodenough; David L Paul
Journal:  Nat Rev Mol Cell Biol       Date:  2003-04       Impact factor: 94.444

3.  Endothelium-specific replacement of the connexin43 coding region by a lacZ reporter gene.

Authors:  M Theis; C de Wit ; T M Schlaeger; D Eckardt; O Krüger; B Döring; W Risau; U Deutsch; U Pohl; K Willecke
Journal:  Genesis       Date:  2001-01       Impact factor: 2.487

Review 4.  Connexins and pannexins in the skeleton: gap junctions, hemichannels and more.

Authors:  Lilian I Plotkin; Joseph P Stains
Journal:  Cell Mol Life Sci       Date:  2015-06-20       Impact factor: 9.261

5.  Regulation of connexin-43-mediated growth inhibition by a phosphorylatable amino-acid is independent of gap junction-forming ability.

Authors:  Xitong Dang; Madhumathy Jeyaraman; Elissavet Kardami
Journal:  Mol Cell Biochem       Date:  2006-05-23       Impact factor: 3.396

6.  Cell autonomous requirement of connexin 43 for osteocyte survival: consequences for endocortical resorption and periosteal bone formation.

Authors:  Nicoletta Bivi; Keith W Condon; Matthew R Allen; Nathan Farlow; Giovanni Passeri; Lucas R Brun; Yumie Rhee; Teresita Bellido; Lilian I Plotkin
Journal:  J Bone Miner Res       Date:  2012-02       Impact factor: 6.741

7.  The carboxy-terminal tail of connexin43 gap junction protein is sufficient to mediate cytoskeleton changes in human glioma cells.

Authors:  Sophie Crespin; John Bechberger; Marc Mesnil; Christian C Naus; Wun-Chey Sin
Journal:  J Cell Biochem       Date:  2010-06-01       Impact factor: 4.429

8.  Connexin 43 deficiency desensitizes bone to the effects of mechanical unloading through modulation of both arms of bone remodeling.

Authors:  Shane A Lloyd; Alayna E Loiselle; Yue Zhang; Henry J Donahue
Journal:  Bone       Date:  2013-07-24       Impact factor: 4.398

9.  Deletion of Cx43 from osteocytes results in defective bone material properties but does not decrease extrinsic strength in cortical bone.

Authors:  Nicoletta Bivi; Mark T Nelson; Meghan E Faillace; Jiliang Li; Lisa M Miller; Lilian I Plotkin
Journal:  Calcif Tissue Int       Date:  2012-08-04       Impact factor: 4.333

Review 10.  Measurement of the toughness of bone: a tutorial with special reference to small animal studies.

Authors:  R O Ritchie; K J Koester; S Ionova; W Yao; N E Lane; J W Ager
Journal:  Bone       Date:  2008-06-28       Impact factor: 4.398

View more
  17 in total

1.  Zoledronate and Raloxifene combination therapy enhances material and mechanical properties of diseased mouse bone.

Authors:  Katherine M Powell; Cayla Skaggs; Alexis Pulliam; Alycia Berman; Matthew R Allen; Joseph M Wallace
Journal:  Bone       Date:  2019-06-21       Impact factor: 4.398

2.  Defective signaling, osteoblastogenesis and bone remodeling in a mouse model of connexin 43 C-terminal truncation.

Authors:  Megan C Moorer; Carla Hebert; Ryan E Tomlinson; Shama R Iyer; Max Chason; Joseph P Stains
Journal:  J Cell Sci       Date:  2017-01-03       Impact factor: 5.285

3.  Even with rehydration, preservation in ethanol influences the mechanical properties of bone and how bone responds to experimental manipulation.

Authors:  Evan O Vesper; Max A Hammond; Matthew R Allen; Joseph M Wallace
Journal:  Bone       Date:  2017-01-03       Impact factor: 4.398

4.  Connexin43 and Runx2 Interact to Affect Cortical Bone Geometry, Skeletal Development, and Osteoblast and Osteoclast Function.

Authors:  Atum M Buo; Ryan E Tomlinson; Eric R Eidelman; Max Chason; Joseph P Stains
Journal:  J Bone Miner Res       Date:  2017-05-22       Impact factor: 6.741

Review 5.  Pro-inflammatory Cytokines and Osteocytes.

Authors:  Miao Zhou; Shuyi Li; Janak L Pathak
Journal:  Curr Osteoporos Rep       Date:  2019-06       Impact factor: 5.096

6.  Iron deficiency and high-intensity running interval training do not impact femoral or tibial bone in young female rats.

Authors:  Jonathan M Scott; Elizabeth A Swallow; Corinne E Metzger; Rachel Kohler; Joseph M Wallace; Alexander J Stacy; Matthew R Allen; Heath G Gasier
Journal:  Br J Nutr       Date:  2021-11-11       Impact factor: 4.125

Review 7.  Connexin43 and the Intercellular Signaling Network Regulating Skeletal Remodeling.

Authors:  Megan C Moorer; Joseph P Stains
Journal:  Curr Osteoporos Rep       Date:  2017-02       Impact factor: 5.096

Review 8.  Cortical bone development, maintenance and porosity: genetic alterations in humans and mice influencing chondrocytes, osteoclasts, osteoblasts and osteocytes.

Authors:  Tsuyoshi Isojima; Natalie A Sims
Journal:  Cell Mol Life Sci       Date:  2021-07-01       Impact factor: 9.261

9.  Osteocytic miR21 deficiency improves bone strength independent of sex despite having sex divergent effects on osteocyte viability and bone turnover.

Authors:  Hannah M Davis; Padmini J Deosthale; Rafael Pacheco-Costa; Alyson L Essex; Emily G Atkinson; Mohammad W Aref; Julian E Dilley; Teresita Bellido; Mircea Ivan; Matthew R Allen; Lilian I Plotkin
Journal:  FEBS J       Date:  2019-10-08       Impact factor: 5.542

10.  Limited impacts of thermoneutral housing on bone morphology and mechanical properties in growing female mice exposed to external loading and raloxifene treatment.

Authors:  Carli A Tastad; Rachel Kohler; Joseph M Wallace
Journal:  Bone       Date:  2021-02-19       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.